Ara
Toplam kayıt 4, listelenen: 1-4
In response to comment on "Autoimmune post-COVID vaccine syndromes: Does the spectrum of autoimmune/inflammatory syndrome expand?" by Jara LJ et al
(Springer London Ltd, 2022)
We thank Dr. Kunal Chandwar for their interest in our article “Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/infammatory syndrome expand?” Indeed, we have included all of the COVID-19 vaccines, ...
The use of a novel smartphone app for monitoring male luts treatment during the COVID-19 outbreak
(Springer Nature, 2020)
We are still experiencing the consequences from the globalCOVID-19 pandemic [1]. The public health emergency hasresulted in a significant reallocation of health resources,with the consequent reorganization of all clinical ...
Infectious side effects of baricitinib: A big data analysis based on VigiBase
(Elsevier B.V., 2023)
Dear Editor, Baricitinib (known as “Olumiant”), is an inhibitor of Janus- associated kinase 1 and 2 (JAK1 and JAK2) initially introduced for the treatment of rheumatoid arthritis (RA), and later for systemic lupus erythematosus ...
Use of favipiravir in lactating mother with COVID-19
(AVES, 2021)
SARS-CoV-2 virus, which appeared in Wuhan, China in December 2019 and spread rapidly all over the world, affects children of all ages.1,2 During the COVID-19 pandemic, nursing mothers are worried about breastfeeding. Similar ...